UBS analyst Graham Doyle upgraded GE HealthCare (GEHC) to Neutral from Sell with a $73 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech
- GE HealthCare announces intended expansion of radiation oncology portfolio
- GE HealthCare participates in a conference call with JPMorgan
- Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
- GE HealthCare price target lowered to $89 from $103 at Wells Fargo